ULBI logo

Ultralife Corporation (ULBI)

$15.61

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ULBI

Market cap

$260113629

EPS

-0.39

P/E ratio

--

Price to sales

0.56

Dividend yield

--

Beta

0.778255

Price on ULBI

Previous close

$6.36

Today's open

$15.61

Day's range

$15.60 - $15.67

52 week range

$4.90 - $15.67

Profile about ULBI

CEO

Michael E. Manna

Employees

671

Headquarters

Newark, NY

Exchange

NASDAQ Global Market

Shares outstanding

16663269

Issue type

Common Stock

ULBI industries and sectors

Industrials

Industrial Goods

News on ULBI

ULBI SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES ULTRALIFE CORPORATION

ULBI shareholders will receive just $16.00 per share in a transaction with an enterprise value of approximately $320 million; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 28, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Ultralife (NASDAQ: ULBI) by EnerSys, provides fair value to Ultralife's public shareholders and whether Ultralife's Board adequately protected shareholder interests in negotiating and approving the transaction. Are You a ULBI Shareholder?

news source

PRNewsWire • Oct 28, 2026

news preview

ULBI Stock Alert: Halper Sadeh LLC is Investigating Whether Ultralife Corporation is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Ultralife Corporation (NASDAQ: ULBI) to EnerSys for $16.00 per share in cash.Halper Sadeh encourages Ultralife shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Ultralife and its board of directors violated the fe.

news source

Business Wire • Oct 28, 2026

news preview

Ultralife Stock Soars After EnerSys Agrees to $320M Buyout

Ultralife Corp. (NASDAQ:ULBI) shares more than doubled Wednesday after the battery maker agreed to an all-cash acquisition by EnerSys (NYSE:ENS).

news source

Benzinga • Oct 28, 2026

news preview

Ultralife Stock Soars 145%. EnerSys to Buy It for the ‘Battlefield of the Future.

Shares of Ultralife were on pace for their best trading day ever after defense company EnerSys said it will be acquiring the battery systems company for $320 million.

news source

Barrons • Oct 28, 2026

news preview

EnerSys to Acquire Ultralife Corporation in a $320 Million All-Cash Transaction

NEWARK, N.Y., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has entered into an Agreement and Plan of Merger (“merger agreement”) with EnerSys (NYSE: ENS) under which upon closing EnerSys will acquire Ultralife Corporation in an all-cash transaction valued at approximately $320 million, including the assumption of net debt.

news source

GlobeNewsWire • Oct 27, 2026

news preview

EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market

READING, Pa.--(BUSINESS WIRE)-- #EnerSys--EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced that it has entered into a definitive agreement to acquire Ultralife (NASDAQ:ULBI) for $16.00 per share in cash, representing a 166% premium to Ultralife's unaffected closing share price on October 26, 2026. The transaction represents an enterprise value of approximately $320 million. EnerSys expects to realize $15 million to $2.

news source

Business Wire • Oct 27, 2026

news preview

Ultralife Upgraded to Neutral on Backlog & Product Commercialization

ULBI's upgrade to Neutral reflects record backlog, product commercialization, manufacturing improvements and broader opportunities from vertical integration.

news source

Zacks Investment Research • Sep 25, 2026

news preview

Ultralife: Well Positioned For Liquidity Despite Low Cash And Declining Cash Flow

Ultralife Corporation maintains a Buy rating, supported by strong working capital, declining debt, and improving profitability despite recent cash flow concerns. ULBI's Q2-2026 results show significant year-over-year gains in operating income and adjusted EBITDA, aided by a $1.1 million tariff refund. Liquidity risk is mitigated by a current ratio of 2.9, a quick ratio of 1.11, and management's confidence in converting inventory and receivables into cash.

news source

Seeking Alpha • Sep 21, 2026

news preview

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip

ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.

news source

Zacks Investment Research • Aug 12, 2026

news preview

Ultralife Q2 Earnings Call Highlights

Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.

news source

MarketBeat • Aug 7, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Ultralife Corporation

Open an M1 investment account to buy and sell Ultralife Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ULBI on M1